Clinical Trial Update: Zoster Vaccine to Enhance Protection Against Zoster in Solid-organ Transplantation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a zoster vaccine to enhance protection against herpes zoster in solid-organ transplant recipients, with not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Simplex Virus Infection
• Herpes Zoster

Drugs mentioned

• Zoster vaccine (varicella-zoster vaccine)

Snippet

Sponsor: Oriol Manuel | Conditions: Zoster; Herpes | Phase 2 | Status: NOT_YET_RECRUITING